Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Mounjaro maintenance dose schedule is once weekly, not every two weeks. That's the direct answer. The licensed dosing interval for tirzepatide is seven days, set by clinical trial evidence across thousands of adults, and altering that interval is a clinical decision that belongs with your prescriber, not something to adjust quietly at home. If you're thinking about spacing doses out, there's usually a reason behind it, and understanding what the evidence says will help you have a much more productive conversation. Mounjaro is a prescription-only medicine; a clinician decides both whether it's right for you and how it's taken.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide is engineered to stay active in your body for approximately a week. Its half-life sits at roughly five days, so by the time your next dose is due, there's still enough present to maintain a relatively steady level of the medicine. That consistency is deliberate: the appetite-regulating and gastric-emptying effects that drive weight loss depend on fairly stable concentrations rather than peaks and troughs.
Shift to every two weeks and the trough becomes significant. In the second week, tirzepatide levels fall well below the range tested in trials. The appetite-suppressing effect fades, fullness returns to something closer to your baseline, and any nausea or other side effects that appeared at the start of a dose may return more sharply when the next one arrives, because your body has had longer to clear the medicine. The NHS patient information on tirzepatide is clear that doses should be taken once weekly on the same day each week, with the interval shortened to a minimum of four days only if absolutely necessary. Two weeks sits well outside what the guidance covers.
None of this means people never consider stretching doses. Cost, side effects, or supply can all make it tempting. But the gap between what feels manageable and what the medicine can still do effectively is worth understanding before making that call.
The decision isn't always casual. There are real situations where people wonder about every two weeks: side effects that feel persistent, a pen that didn't arrive on time, a stretch of illness that disrupted the usual routine, or a cost pressure that makes a fortnightly supply feel more sustainable. Each of these deserves a specific answer rather than a blanket rule.
For side effects, the standard clinical approach is to stay at the current dose longer before going up, or to discuss anti-nausea strategies, rather than to halve the frequency. For a missed dose, the Mounjaro Patient Information Leaflet covers what to do (and when to skip to the next scheduled dose instead of catching up), and a prescriber at nume can advise on your specific situation. For supply issues, it's worth understanding how genuine UK-sourced Mounjaro reaches you and what continuity of supply actually looks like through a regulated pharmacy.
Cost is the one context where fortnightly dosing sometimes comes up as a strategy. It's a real concern. On price-context pages you'll find a plain account of what private Mounjaro treatment actually costs and what that includes. But halving your dose frequency isn't the same as managing cost smartly, you're likely halving the effectiveness too.
What all these situations share: the right first move is a conversation, not a unilateral change to your schedule.
A prescriber reviewing your case can look at the whole picture: your current dose, your side-effect profile, how much weight you've lost and over what period, and whether there's a clinical reason to adjust anything. That context makes an enormous difference. They might suggest staying at a lower maintenance dose for longer rather than increasing, and if you're curious whether 2.5 mg could serve as a longer-term maintenance dose for you, that's exactly the kind of question a prescriber can work through with your notes in front of them. They might confirm that a temporary gap due to illness doesn't require any dramatic adjustment. They might identify that the side effects pushing you toward every-two-weeks dosing are actually a sign the titration moved too fast.
At nume, every repeat order is reviewed by a GPhC-registered prescriber before it's dispensed, a real clinician reads your notes, not software. The pen that arrives via DPD the next working day, in plain unbranded packaging, has been through that check. If something has changed in how you're tolerating treatment, that review is the right place to raise it. You can reach the team through our support line, available seven days a week.
If you're not yet on treatment and you're trying to understand what the dose schedule looks like before starting, the full picture on how Mounjaro maintenance dosing works is a good place to start, it covers what 'maintenance' actually means in the context of a titration schedule that runs over months.
People who arrive at this question are usually trying to solve something, a side effect, a cost, a gap in supply, or a sense that weekly feels too frequent. That underlying problem is valid. But every two weeks as a solution almost certainly doesn't match the evidence, and it bypasses the people who can actually help you solve the real thing.
The NICE appraisal of tirzepatide (TA1026) and the licensed clinical evidence are built on weekly dosing. Deviating from that isn't just a minor tweak; it changes the medicine's behaviour in ways that aren't tested or sanctioned. If there's a genuine clinical case for adjusting your schedule, your prescriber is the one who can make that call. If you're still finding your feet with Mounjaro more generally, the tirzepatide overview covers the full licensed use, how it works, and who it's intended for. For a closer look at where the 5mg level sits in the titration journey, the 5mg dose page walks through what that stage typically looks like, including whether 5 mg can actually function as a maintenance dose rather than simply a stepping stone to higher strengths. And if you're still exploring whether treatment is right for you, our weight-loss treatment overview sets out the options clearly.
Speak to our prescribers if something about your current schedule isn't working, that's exactly what they're there for. Start your free consultation and a named clinician will review your situation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.